Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Ohnuma

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[CD26 and its signaling pathway]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Targeted therapy by monoclonal antibodies]Kei Ohnuma, Chikao Morimoto
Leukemia & Lymphoma|August 1, 2002
Cord blood transplantation from HLA-mismatched unrelated donorsKei Ohnuma, Keiichi Isoyama, Hirokazu Nishihira
Nature Immunology|July 22, 2015
DPP4 in anti-tumor immunity: going beyond the enzymeKei Ohnuma, Ryo Hatano, Chikao Morimoto
Trends in Immunology|May 6, 2008
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionKei Ohnuma, Nam H Dang, Chikao Morimoto
Modern Rheumatology|October 5, 2018
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapyKei Ohnuma, Ryo Hatano, Nam H Dang, et al.
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[CD26 and its signaling pathway]Kei Ohnuma, Chikao Morimoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Antibody therapy for malignant mesothelioma: humanized anti-cD26 mAb therapy]Chikao Morimoto, Kei Ohnuma
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Targeted therapy by monoclonal antibodies]Kei Ohnuma, Chikao Morimoto
Leukemia & Lymphoma|August 1, 2002
Cord blood transplantation from HLA-mismatched unrelated donorsKei Ohnuma, Keiichi Isoyama, Hirokazu Nishihira
Nature Immunology|July 22, 2015
DPP4 in anti-tumor immunity: going beyond the enzymeKei Ohnuma, Ryo Hatano, Chikao Morimoto
Trends in Immunology|May 6, 2008
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionKei Ohnuma, Nam H Dang, Chikao Morimoto
Modern Rheumatology|October 5, 2018
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapyKei Ohnuma, Ryo Hatano, Nam H Dang, et al.
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Pageof 9